The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications
Authors
Keywords
Breast cancer, Histone acetylation, Histone deacetylation, Therapy
Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-06-12
DOI
10.1007/s12253-018-0433-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes
- (2016) Terri L. Messier et al. Oncotarget
- The autophagy GABARAPL1 gene is epigenetically regulated in breast cancer models
- (2015) Eric Hervouet et al. BMC CANCER
- Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential
- (2015) Claudia Cava et al. BMC Systems Biology
- Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation
- (2015) TOSHIKI MAWATARI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Epigenetic Modifications, Chromatin Distribution andTP53Transcription in a Model of Breast Cancer Progression
- (2015) Gilson C. Santos et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Histone deacetylase inhibitors promote the expression ofATP2A3gene in breast cancer cell lines
- (2015) Erika Contreras-Leal et al. MOLECULAR CARCINOGENESIS
- Circadian disruption and breast cancer: An epigenetic link?
- (2015) David Z. Kochan et al. Oncotarget
- Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
- (2015) J M Gajer et al. Oncogenesis
- LSD1 Overexpression Is Associated with Poor Prognosis in Basal-Like Breast Cancer, and Sensitivity to PARP Inhibition
- (2015) Satoi Nagasawa et al. PLoS One
- Garcinol, an Acetyltransferase Inhibitor, Suppresses Proliferation of Breast Cancer Cell Line MCF-7 Promoted by 17β-Estradiol
- (2014) Xia Ye et al. Asian Pacific Journal of Cancer Prevention
- Synthesis of a novel series of thiazole-based histone acetyltransferase inhibitors
- (2014) Daniela Secci et al. BIOORGANIC & MEDICINAL CHEMISTRY
- High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
- (2014) Remco S Derr et al. BMC CANCER
- A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression
- (2014) Jangsoon Lee et al. BREAST CANCER RESEARCH AND TREATMENT
- The increasing roles of epigenetics in breast cancer: Implications for pathogenicity, biomarkers, prevention and treatment
- (2014) Clémence Basse et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
- (2014) Jinwon Seo et al. Journal of Breast Cancer
- Histone acetyltransferase inhibitor II induces apoptosis in glioma cell lines via the p53 signaling pathway
- (2014) Li-Xiao Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitors Improve the Replication of Oncolytic Herpes Simplex Virus in Breast Cancer Cells
- (2014) James J. Cody et al. PLoS One
- C646, a selective small molecule inhibitor of histone acetyltransferase p300, radiosensitizes lung cancer cells by enhancing mitotic catastrophe
- (2014) Takahiro Oike et al. RADIOTHERAPY AND ONCOLOGY
- Epigenetic mechanisms of breast cancer: an update of the current knowledge
- (2014) Seher Karsli-Ceppioglu et al. Epigenomics
- BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10
- (2014) Chang Gong et al. Nature Communications
- Rational design and validation of a Tip60 histone acetyltransferase inhibitor
- (2014) Chunxia Gao et al. Scientific Reports
- Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer
- (2014) Tao Zhang et al. NEOPLASIA
- Histone acetyltransferase p300 promotes MKL1-mediated transactivation of catechol-O-methyltransferase gene
- (2013) Z. Liu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Male breast cancer: genetics, epigenetics, and ethical aspects
- (2013) P. Rizzolo et al. ANNALS OF ONCOLOGY
- Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
- (2013) Berit Maria Müller et al. BMC CANCER
- Histone deacetylase inhibitors modulate miRNA and mRNA expression, block metaphase, and induce apoptosis in inflammatory breast cancer cells
- (2013) Namita Chatterjee et al. CANCER BIOLOGY & THERAPY
- The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
- (2013) M. A. Salvador et al. CLINICAL CANCER RESEARCH
- Genomic classifications and radiotherapy for breast cancer
- (2013) Anna Britten et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Loss of Epigenetic Kruppel-like Factor 4 Histone Deacetylase (KLF-4-HDAC)-mediated Transcriptional Suppression Is Crucial in Increasing Vascular Endothelial Growth Factor (VEGF) Expression in Breast Cancer
- (2013) Alpana Ray et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents
- (2013) H. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Acetyltransferases (HATs) as Targets for Neurological Therapeutics
- (2013) Anne Schneider et al. Neurotherapeutics
- Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt
- (2013) Scott Thomas et al. PLoS One
- Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Enhances Radiosensitivity and Suppresses Lung Metastasis in Breast Cancer In Vitro and In Vivo
- (2013) Hui-Wen Chiu et al. PLoS One
- Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat)
- (2012) Makoto Kubo et al. BREAST CANCER RESEARCH AND TREATMENT
- EGCG suppresses prostate cancer cell growth modulating acetylation of androgen receptor by anti-histone acetyltransferase activity
- (2012) Ho-Geun Yoon INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Epigenetics as a Therapeutic Target in Breast Cancer
- (2012) Roisin Connolly et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Epigenetic Events Associated with Breast Cancer and Their Prevention by Dietary Components Targeting the Epigenome
- (2011) Shabana I. Khan et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Epigenetic Therapy for Breast Cancer
- (2011) Feng-Feng Cai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RETRACTED: Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer
- (2010) María E. Fermento et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors
- (2010) Mario Federico et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The epigenetics of breast cancer
- (2010) Jovana Jovanovic et al. Molecular Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More